Bill Ackman had a famously bad time with Valeant Pharmaceuticals (VRX), which crashed from $263 to the single digits. Last March, having suffered terrible losses for his fund, Ackman “threw in the ...
Really. Not a whole lot more to add about my dog’s just expression until something dramatic happens. We both seek excitement. Surely for her, excitement comes in the form of a treat or a walk. Yet I...
Two days of gains have helped re-establish the bullish technical picture for tech indices, Nasdaq and Nasdaq 100. While the improvement was welcomed it didn’t come without a price. The Nasdaq br...
The S&P opened above this week’s previous daily opens and briefly oscillated around a narrow point until it steadied and closed the day with a small gain of 0.19%. The index is up 0.93% sinc...
Janet Yellen’s testimony before the House committee was what drove markets on Wednesday. The key takeaway from the testimony was that she was moderately more dovish than she was previously. This dov...
The Chart of the Day belongs to SeaSpine Holdings (SPNE). I found the medical technology stock by using Barchart to sort today’s Top Stocks to Own list first by the most frequent number ...
U.S. stocks were on track for a new record on Thursday as Fed Chair Janet Yellen’s testimony made bulls feel even bolder than they have for most of this year. The strong gains are even more time...
The stars — in the form of smart and dumb money futures contract positions — have once again lined up favorably for precious metals. Here are those positions for gold and silver as of Tuesday the ...
Yellen’s speaking again… give it all you’ve got!! Stocks stalled early on (around 1010ET) thanks to inflation comments from Yellen, but that dip was bid back to the highs… then...
To the naked eye, it represents progress. China has still an enormous rural population doing subsistence level farming. As the nation grows economically, such a way of life is an inherent drag, an anc...